A leader in the ever-changing field of biotechnology.
Lindsay Rosenwald reached various typical and success task in field of medicine and biotechnology investment. Rosenwald's view to give a business opportunity for small companies could be much more benificial for growth, that is small companies have more power to grow more and fast.
In 1991, Lindsay Rosenwald founded the Paramount Group of Companies. That year he formed Paramount Biocapital Inc. which was a company that helps finance new companies in the biotechnology field. It provides financing in several areas, including start up and developing products. By 1994, he was the Chairman of the Paramount Group. A year later, Biocapital began to provide merchant banking for the life sciences industry.
Since its inception, the Paramount Group has grown substantially. The largest companies that have been added in its list are Paramount Biosciences and Paramount Corporate Development. Paramount Biosciences is an investment company, and Paramount Corporate Development is a development company. The company specializes in corporate and drug development within the group's portfolio companies.
Many companies Lindsay Rosenwald has founded through the Paramount Group have made a significant impact on the biotechnology field. Some of the companies he has found were immediately popular simply because they were formed. For example, he founded the first gene therapy company and cancer vaccine company that were traded publicly. One of his portfolio companies also set the record for the fastest FDA approval time for a medicine in the United States. That product was Arsenic Trioxide, which was developed to treat Leukemia. It went through the FDA approval process in less than 30 months. He also founded Cougar Biotechnology, which is the only company within the biotechnology field to be sold based on one product that had yet to complete the FDA approval process. In 2009, the company was bought by Johnson & Johnson for one billion dollars. The product they were so interested in was developed to treat prostate cancer.